Tim Wentworth is the right choice to lead Walgreens (WBA) in its transition to offering more health-care services, CNBC's Jim Cramer said Wednesday.
, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services.
"This guy is the real deal. I just salute him and think he can take you to a higher price, and the stock should be bought — perhaps aggressively," Cramer said onafter former chief executive Roz Brewer left her post. The company said it was seeking a new CEO who had "deep" experience in the health-care industry.
Shares of Walgreens rose more than 1% Wednesday, to $22.66. However, so far in 2023, the Dow Jones Industrial Average constituent is down nearly 40%.Jim's Charitable Trust
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street stabilizes: The Dow, the S&P 500 and the Nasdaq little changed early Tuesday.
Lire la suite »
Jim Cramer's top 10 things to watch in the stock market WednesdayFutures tied to the Dow, the S&P 500 and the Nasdaq are higher.
Lire la suite »
Jim Cramer says activist investor Nelson Peltz's new battle with Disney is warranted“Peltz correctly noticed that the stock is down huge and that’s probably not right,” CNBC’s Jim Cramer said Tuesday.
Lire la suite »
Jim Cramer thinks 'Mr. Bitcoin is about to go down big'CNBC's loudest financial advisor appears frustrated by the current investment landscape and thinks bitcoin is of no interest.
Lire la suite »
Jim Cramer explains why the Israel-Hamas war may not steer Monday's market actionCNBC’s Jim Cramer suggested the deadly conflict between Israel and Hamas may not be the driving force in Monday’s market action.
Lire la suite »
Jim Cramer says investors should wait and see with Birkenstock's IPOCNBC's Jim Cramer on Monday told investors they may be wise to sit out Wednesday's Birkenstock IPO.
Lire la suite »